Figures & data
Table 1. Baseline characteristics of the study population (n = 195).
Figure 1. Kaplan-Meier plots showing freedom from locoregional progression, freedom from any progression, disease-specific survival, overall survival, and disease-free survival.
![Figure 1. Kaplan-Meier plots showing freedom from locoregional progression, freedom from any progression, disease-specific survival, overall survival, and disease-free survival.](/cms/asset/af9c77a8-5437-4ab7-b432-24239f8806ed/ionc_a_1581375_f0001_c.jpg)
Figure 2. Kaplan-Meier plots showing cumulative incidence of late grade ≥3 toxicity in 182 patients.
![Figure 2. Kaplan-Meier plots showing cumulative incidence of late grade ≥3 toxicity in 182 patients.](/cms/asset/d1a82d66-a249-403d-a011-5b2af03eea82/ionc_a_1581375_f0002_b.jpg)
Figure 3. Kaplan-Meier plots showing cumulative incidence of specific late grade ≥3 toxicity in 182 patients.
![Figure 3. Kaplan-Meier plots showing cumulative incidence of specific late grade ≥3 toxicity in 182 patients.](/cms/asset/30382fad-f19b-42b6-bd5d-9f777c99bac3/ionc_a_1581375_f0003_b.jpg)
Table 2. Distribution of maximum toxicity scores in 182 evaluated patients (crude numbers).
Table 3. Prognostic factors for grade ≥3 late toxicity.